Gordon LI - Search Results

1

A phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: analysis of response, toxicity, and dose intensity.

Gordon LI, Young M, Weller E, Habermann TM, Winter JN, Glick J, Ghosh C, Flynn P, Cassileth PA. Gordon LI, et al. Blood. 1999 Nov 15;94(10):3307-14. Blood. 1999. PMID: 10552939 Free article. Clinical Trial.

2

Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas.

Winter JN, Andersen J, Variakojis D, Gordon LI, Fisher RI, Oken MM, Neiman RS, Jiang S, Bauer KD. Winter JN, et al. Among authors: gordon li. Blood. 1996 Nov 15;88(10):3919-25. Blood. 1996. PMID: 8916958 Free article. Clinical Trial.

3

Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: determination of the maximum-tolerated dose of ProMACE-CytaBOM.

Gordon LI, Anderson J, Habermann TM, Winter JN, Glick J, Schilder RJ, Cassileth P. Gordon LI, et al. J Clin Oncol. 1996 Apr;14(4):1275-81. doi: 10.1200/JCO.1996.14.4.1275. J Clin Oncol. 1996. PMID: 8648384 Clinical Trial.

4

Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.

Gordon LI, Andersen J, Colgan J, Glick J, Resnick GD, O'Connell M, Cassileth PA. Gordon LI, et al. Cancer. 1995 Feb 1;75(3):865-73. doi: 10.1002/1097-0142(19950201)75:3<865::aid-cncr2820750319>3.0.co;2-z. Cancer. 1995. PMID: 7530168 Clinical Trial.

5

High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer.

Tallman MS, Rademaker AW, Jahnke L, Brown SG, Bauman A, Mangan C, Kelly C, Rubin H, Kies MS, Shaw J, Kiel K, Gordon LI, Gradishar WJ, Winter JN. Tallman MS, et al. Among authors: gordon li. Bone Marrow Transplant. 1997 Nov;20(9):721-9. doi: 10.1038/sj.bmt.1700962. Bone Marrow Transplant. 1997. PMID: 9384473 Clinical Trial.

6

BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study.

Winter JN, Andersen J, Reed JC, Krajewski S, Variakojis D, Bauer KD, Fisher RI, Gordon LI, Oken MM, Jiang S, Jeffries D, Domer P. Winter JN, et al. Among authors: gordon li. Blood. 1998 Feb 15;91(4):1391-8. Blood. 1998. PMID: 9454770 Free article. Clinical Trial.

7

Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology Group.

Hochster HS, Oken MM, Winter JN, Gordon LI, Raphael BG, Bennett JM, Cassileth PA. Hochster HS, et al. Among authors: gordon li. J Clin Oncol. 2000 Mar;18(5):987-94. doi: 10.1200/JCO.2000.18.5.987. J Clin Oncol. 2000. PMID: 10694548 Clinical Trial.

8

Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphoma.

Evens AM, Altman JK, Mittal BB, Hou N, Rademaker A, Patton D, Kaminer L, Williams S, Duffey S, Variakojis D, Singhal S, Tallman MS, Mehta J, Winter JN, Gordon LI. Evens AM, et al. Among authors: gordon li. Ann Oncol. 2007 Apr;18(4):679-88. doi: 10.1093/annonc/mdl496. Epub 2007 Feb 16. Ann Oncol. 2007. PMID: 17307757 Free article. Clinical Trial.

9

Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.

Gordon LI, Harrington D, Andersen J, Colgan J, Glick J, Neiman R, Mann R, Resnick GD, Barcos M, Gottlieb A, et al. Gordon LI, et al. N Engl J Med. 1992 Nov 5;327(19):1342-9. doi: 10.1056/NEJM199211053271903. N Engl J Med. 1992. PMID: 1383819 Free article. Clinical Trial.

10

Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?

Mehta J, Gordon LI, Tallman MS, Winter JN, Evens AM, Frankfurt O, Williams SF, Grinblatt D, Kaminer L, Meagher R, Singhal S. Mehta J, et al. Among authors: gordon li. Bone Marrow Transplant. 2006 Jul;38(2):95-100. doi: 10.1038/sj.bmt.1705388. Epub 2006 Jun 5. Bone Marrow Transplant. 2006. PMID: 16751789

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

444 results

Search Page